The Lustgarten Foundation is the largest private funder of pancreatic cancer research in the world and has directed nearly two-thirds of the world’s private funding for research from organizations solely focused on this disease. We are transforming pancreatic cancer outcomes, so patients live longer, healthier lives.
There Has Never Been a More Hopeful Time for Patients As the driving force behind creating a new era in pancreatic cancer research, the Lustgarten Foundation funds the most talented researchers from around the world who make it their life’s work to understand and treat this disease. Major accomplishments include sequencing the pancreatic cancer genome; identifying impediments to drug delivery; funding research surrounding Abraxane, which remains the standard of care for many patients; adding Keytruda®—the first FDA-approved immunotherapy for advanced pancreatic cancer patients with a specific mutation—to the growing number of treatment options; and establishing Lustgarten-funded dedicated laboratories.
Annual Reports and Financials
You Fund The Cure Thanks to separate funding to support administrative expenses, 100% of your donation funds pancreatic cancer research. We are the only private pancreatic cancer organization able to make this claim.
Pancreatic Cancer Research Milestones
Since our founding in 1998 we have led the way in funding pancreatic cancer research, advancing treatments and improving patient outcomes faster than ever before.